Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-31

Clinical Trial Update: ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot trial evaluating whether ACE inhibitors can reduce lymphoid fibrosis in HIV-infected patients on antiretroviral therapy; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACE inhibitors

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV | Phase 4 | Status: COMPLETED | Results posted: 2016-03-31